| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSKB
|
11.04 | 30.9B | 2.80 | 0.67 | — | — | — | 79 | 31 | 17.91 | +39.8% | 100 | 6.44 |
|
ALBRK
|
8.67 | 21.7B | 2.63 | 0.74 | — | — | — | 74 | 35 | 13.70 | +37.1% | 88 | 5.04 |
|
ISCTR
|
12.95 | 323.8B | 4.25 | 0.77 | — | — | — | 72 | 21 | 16.51 | +17.6% | 89 | 3.08 |
|
GARAN
|
131.40 | 551.9B | 4.61 | 1.13 | — | — | — | 70 | 21 | 132.77 | +0.7% | 100 | 1.13 |
|
VAKBN
|
33.74 | 334.6B | 4.62 | 0.99 | — | — | — | 69 | 20 | 37.10 | +6.4% | 100 | 2.78 |
|
AKBNK
|
71.55 | 372.1B | 5.30 | 1.15 | — | — | — | 65 | 18 | 64.25 | -6.5% | 92 | 1.77 |
|
YKBNK
|
35.90 | 303.2B | 5.64 | 1.06 | — | — | — | 62 | 18 | 33.10 | -5.0% | 88 | 3.86 |
|
SKBNK
|
6.29 | 15.7B | 5.76 | 0.78 | — | — | — | 61 | 19 | 6.89 | +6.0% | 84 | 3.04 |
|
KLNMA
|
8.89 | 88.9B | 9.87 | 2.64 | — | — | — | 51 | 10 | 4.42 | -32.2% | 93 | 4.16 |
|
HALKB
|
49.44 | 355.2B | 11.75 | 1.57 | — | — | — | 43 | 12 | 30.21 | -26.8% | 85 | 3.24 |
|
ICBCT
|
18.98 | 16.3B | 8.44 | 2.90 | — | — | — | 42 | 8 | 9.70 | -28.9% | 53 | 11.40 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.